abstract |
The present invention relates in various aspects to recombinant poxviruses comprising nucleic acids encoding SARS-CoV-2 viral proteins, methods of making such viruses, and uses of such viruses. Recombinant poxviruses are particularly well suited as protective viral vaccines against the SARS-CoV-2 virus. |